STOCK PLUMMETS AFTER NOVO NORDISK DEAL COLLAPSE

Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending HIMS's stock price plummeting by nearly 10%. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate that it could be